Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Dalgard

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Follow-up studies of treatment for hepatitis C virus infection among injection drug usersOlav Dalgard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 15, 2011
[New guidelines for investigation and treatment of hepatitis C]Olav Dalgard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 10, 2009
[Patients on maintenance therapy for opiate dependence should be treated for hepatitis C]Olav Dalgard, Steinar Skrede
Drugs|October 17, 2006
Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infectionOlav Dalgard, Alessandra Mangia
Hepatology (Baltimore, Md.)|July 31, 2008
Short treatment to patients with genotype 2 or 3Olav Dalgard, Alessandra Mangia
Hepatology (Baltimore, Md.)|June 26, 2009
Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelinesOlav Dalgard, Alessandra Mangia
BMC Infectious Diseases|September 26, 2014
No strategy to meet the HCV epidemicOlav Dalgard, Stefan Mauss
Pharmacogenomics and Personalized Medicine|December 11, 2012
Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirinRoberto J Carvalho-Filho, Olav Dalgard
Alimentary Pharmacology & Therapeutics|December 9, 2024
Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone? Authors' ReplyAsgeir Johannessen, Dag Henrik Reikvam, Olav Dalgard
The Lancet. Gastroenterology & Hepatology|June 25, 2021
Hepatitis C in Iceland: a milestone for global eliminationOlav Dalgard, Håvard Midgard, Knut Boe Kielland
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 16, 2005
Follow-up studies of treatment for hepatitis C virus infection among injection drug usersOlav Dalgard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|January 15, 2011
[New guidelines for investigation and treatment of hepatitis C]Olav Dalgard
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 10, 2009
[Patients on maintenance therapy for opiate dependence should be treated for hepatitis C]Olav Dalgard, Steinar Skrede
Drugs|October 17, 2006
Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infectionOlav Dalgard, Alessandra Mangia
Hepatology (Baltimore, Md.)|July 31, 2008
Short treatment to patients with genotype 2 or 3Olav Dalgard, Alessandra Mangia
Hepatology (Baltimore, Md.)|June 26, 2009
Management of patients with hepatitis C virus genotype 2 or 3: comments on updated American Association for the Study of Liver Diseases practice guidelinesOlav Dalgard, Alessandra Mangia
BMC Infectious Diseases|September 26, 2014
No strategy to meet the HCV epidemicOlav Dalgard, Stefan Mauss
Pharmacogenomics and Personalized Medicine|December 11, 2012
Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirinRoberto J Carvalho-Filho, Olav Dalgard
Alimentary Pharmacology & Therapeutics|December 9, 2024
Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone? Authors' ReplyAsgeir Johannessen, Dag Henrik Reikvam, Olav Dalgard
The Lancet. Gastroenterology & Hepatology|June 25, 2021
Hepatitis C in Iceland: a milestone for global eliminationOlav Dalgard, Håvard Midgard, Knut Boe Kielland
Pageof 11